Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

NKTR

Nektar Therapeutics

May 08 • 04:00PM ET

81.89

-1.48 -1.78 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: JANX ARVN XNCR IOVA ALLO

| Held by: VTI VXF SCHA XPH IHE VHT PRFZ LFSC DWAS ITOT

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-8.42	Insider Own	2.15%	Shs Outstand	33.21M	Perf Week	-5.29%
Market Cap	2.72B	Forward P/E	-	EPS next Y	-11.17	Insider Trans	-1.17%	Shs Float	32.50M	Perf Month	5.19%
Enterprise Value	2.29B	PEG	-	EPS next Q	-2.06	Inst Own	66.37%	Short Float	11.17%	Perf Quarter	122.47%
Income	-158.10M	P/S	48.89	EPS this Y	5.73%	Inst Trans	24.55%	Short Ratio	2.84	Perf Half Y	50.92%
Sales	55.63M	P/B	2.90	EPS next Y	-21.79%	ROA	-31.01%	Short Interest	3.63M	Perf YTD	93.68%
Book/sh	28.28	P/C	4.78	EPS next 5Y	-5.46%	ROE	-53.60%	52W High	109.00 -24.87%	Perf Year	782.10%
Cash/sh	17.12	P/FCF	-	EPS past 3/5Y	30.93% 23.59%	ROIC	-22.68%	52W Low	7.99 924.91%	Perf 3Y	609.00%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-15.66% -18.43%	Gross Margin	98.65%	Volatility	4.26% 5.67%	Perf 5Y	-72.84%
Dividend TTM	-	EV/Sales	41.25	EPS Y/Y TTM	11.52%	Oper. Margin	-224.08%	ATR (14)	4.93	Perf 10Y	-59.20%
Dividend Ex-Date	-	Quick Ratio	10.21	Sales Y/Y TTM	-36.24%	Profit Margin	-284.18%	RSI (14)	48.16	Recom	1.20
Dividend Gr. 3/5Y	- -	Current Ratio	10.21	EPS Q/Q	49.83%	SMA20	-5.61%	Beta	-0.76	Target Price	155.12
Payout	-	Debt/Eq	0.25	Sales Q/Q	3.83%	SMA50	4.70%	Rel Volume	0.56	Prev Close	83.37
Employees	63	LT Debt/Eq	0.21	Earnings	May 07 AMC	SMA200	48.22%	Avg Volume	1.28M	Price	81.89
IPO	May 03, 1994	Option/Short	Yes / Yes	EPS/Sales Surpr.	-15.02% 1.59%	Trades		Volume	720,598	Change	-1.78%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)